A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors
Eli Lilly and Company
Eli Lilly and Company
KaliVir Immunotherapeutics
VLP Therapeutics
Memorial Sloan Kettering Cancer Center
University of Chicago
Bicara Therapeutics
University of Pittsburgh
Abramson Cancer Center at Penn Medicine